Acasti Pharma Inc. (ACST)

USD 3.37

(4.01%)

Annual Income Statements

(In USD)
Breakdown 2024 2023 2022 2021 2020 2019
Revenue - - - 196 Thousand - -
Cost of Revenue 11 Thousand 52.15 Million 15.58 Million 76 Thousand 2.32 Million 2.33 Million
Gross Profit -11 Thousand -52.15 Million -15.58 Million 120 Thousand -2.32 Million -2.33 Million
Operating Expenses 11.3 Million 18.24 Million 15.34 Million 10.83 Million 24.43 Million 32.97 Million
Selling, General and Administrative Expenses 6.67 Million 8.21 Million 9.78 Million 6.65 Million 8.46 Million 4.23 Million
Research and Development Expenses 4.62 Million 9.97 Million 5.55 Million 4.17 Million 15.97 Million 28.73 Million
Other Expenses - 63 Thousand - 8000.00 - -
Cost and Expenses 11.31 Million 18.24 Million 15.34 Million 10.91 Million 24.43 Million 32.97 Million
Operating Income -11.31 Million 15.72 Million -15.58 Million -10.71 Million -24.43 Million -33.71 Million
Interest Expense 911 Thousand 67.69 Million 224 Thousand 264 Thousand 247 Thousand 273.36 Thousand
Income Tax Expense -1.77 Million -9.54 Million -648 Thousand -127 Thousand 247 Thousand 5.24 Million
Earnings before Tax -14.63 Million -51.97 Million -10.46 Million -19.67 Million -25.51 Million -38.62 Million
Net Income -12.85 Million -42.42 Million -9.81 Million -19.67 Million -25.76 Million -43.86 Million
Earnings Per Share Basic -1.35 -5.71 -1.60 -7.96 -14.62 -6.46
Earnings Per Share Diluted -1.35 -5.71 -1.60 -7.96 -14.62 -6.46
Weighted Average Shares Outstanding 9.52 Million 7.43 Million 6.14 Million 2.47 Million 1.76 Million 6.78 Million
Weighted Average Shares Outstanding (Diluted) 9.52 Million 7.43 Million 6.14 Million 2.47 Million 1.76 Million 6.78 Million
Gross Margin - - - 0.61 - -
EBIT Margin - - - -50.76 - -
Profit Margin - - - -100.40 - -
EBITDA -11.3 Million 15.84 Million -19.98 Million -12.3 Million -21.82 Million -30.98 Million
Earnings Before Tax Margin - - - -54.67 - -

Income Statement Charts